interpreting-urinalysis

name: interpreting-urinalysis language: en description: Structures complete urinalysis interpretation with microscopy correlation and clinical significance. Use when interpreting UA results, correlating microscopy findings, or evaluating renal function markers. tags:

• analysis
• pathology
• clinical metadata: author: casemark practice_areas:
  • Pathology
  • Laboratory Medicine document_types:
  • Interpretation Report skill_modes:
  • Analysis
  • Interpretation

Interpreting Urinalysis

Structures complete urinalysis interpretation with microscopy correlation and clinical significance.

Why This Skill Exists

Urinalysis is one of the most frequently ordered laboratory tests, providing critical information for diagnosing urinary tract infections, renal disease, diabetes, liver disease, and systemic conditions. Despite its ubiquity, urinalysis interpretation is frequently oversimplified, leading to missed diagnoses (nephrotic-range proteinuria attributed to "benign" proteinuria, dysmorphic RBCs indicating glomerular disease missed on microscopy, casts overlooked in a spun sediment). The CLSI GP16-A3 guideline and the European Confederation of Laboratory Medicine consensus provide standardized urinalysis methodology.

CAP accreditation (Urinalysis checklist, URN series) requires documented procedures for dipstick and microscopy, quality control of reagent strips, and competency assessment for personnel performing microscopic examination. CLIA classifies provider-performed microscopy (PPM) as a distinct complexity category with specific requirements. Automated urine analyzers are increasingly replacing manual microscopy, but correlation and reflex manual review remain essential for abnormal findings.

Checkpoint A: Pre-Draft Intake (Mandatory)

1. Specimen type — Clean-catch midstream, catheterized, pediatric bag, suprapubic aspirate, or random void? Default: clean-catch midstream.
2. Clinical indication — UTI screening, renal disease evaluation, proteinuria workup, hematuria evaluation, diabetes monitoring, or pre-operative? Default: screening.
3. Collection time — Was the specimen a first morning void (preferred for protein and casts) or random? Default: random.
4. Time since collection — How long between collection and analysis? Default: < 2 hours.
5. Patient context — Age, sex, menstrual status (potential contaminant), catheter use, pregnancy, medications (pyridium, rifampin, nitrofurantoin)? Default: adult, no interfering medications.
6. Concurrent labs — Serum creatinine, BUN, CBC, urine culture results? Default: not available.
7. Dipstick vs. complete UA — Is microscopy included or dipstick only? Default: complete UA with microscopy.

Documents to Request

• Urinalysis requisition with clinical indication
• Specimen collection method documentation
• Current dipstick reagent strip lot and QC results
• Automated analyzer results (if using automated microscopy)
• Serum chemistry results (creatinine, BUN, albumin, glucose)
• Prior urinalysis results for trending
• Urine culture results (if ordered concurrently)
• Clinical notes (symptoms, medications, renal history)

Step 1: Specimen Assessment and Dipstick (Chemical) Analysis

Evaluate the macroscopic and chemical strip parameters:

Dipstick Parameters and Clinical Significance

Critical dipstick combinations:

• LE positive + nitrite positive: High specificity (> 95%) for UTI
• Protein 3+ with specific gravity < 1.015: Suggests significant proteinuria (not concentration artifact)
• Blood positive with no RBCs on microscopy: Hemoglobinuria or myoglobinuria

Step 2: Microscopic Examination

Perform standardized microscopy (CLSI GP16-A3):

Preparation: Centrifuge 12 mL at 400g for 5 minutes; resuspend sediment in 0.5-1.0 mL supernatant.

Formed Elements — Low Power (10x) and High Power (40x)

Casts — Identified on Low Power (10x)

Crystals

Step 3: Integrated Interpretation

Correlate dipstick and microscopy findings into a clinical interpretation:

Infection pattern: LE+, nitrite+, WBC > 5/HPF, bacteria moderate/many, +/- WBC casts (pyelonephritis). Glomerular disease pattern: Protein 2-3+, blood+, dysmorphic RBCs, RBC casts, +/- fatty casts (nephrotic component). Tubular injury pattern: Low specific gravity, RTE cells, RTE casts, granular casts, mild proteinuria (predominantly tubular proteins). Nephrotic syndrome pattern: Protein 3-4+, fatty casts (Maltese cross), oval fat bodies, waxy casts, lipiduria. Contamination pattern: Squamous epithelial cells > 5/LPF, bacteria without WBCs, mixed flora.

Step 4: Reflex and Confirmatory Testing

Recommend follow-up testing based on urinalysis findings:

• Proteinuria quantification: If dipstick protein >= 1+, order urine protein-to-creatinine ratio (UPCR) or 24-hour urine protein. Dipstick primarily detects albumin; for tubular proteinuria, use urine total protein.
• Urine albumin-to-creatinine ratio (UACR): For diabetic nephropathy screening (microalbuminuria: 30-300 mg/g; macroalbuminuria: > 300 mg/g).
• Urine culture: If LE+, nitrite+, or clinical UTI suspicion.
• Urine cytology: If hematuria without infection in patients > 40 years or with risk factors for urothelial carcinoma.
• Phase contrast microscopy: For RBC morphology assessment (dysmorphic vs. isomorphic) in hematuria workup.
• Urine electrophoresis: If monoclonal protein suspected (light chains not detected by dipstick).

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Is specimen adequacy assessed (squamous epithelial cell count for contamination)?
2. Are dipstick and microscopy findings correlated (e.g., blood positive with RBC count)?
3. Are pathognomonic findings identified (RBC casts = glomerulonephritis, cystine crystals = cystinuria)?
4. Is the clinical pattern classified (infection, glomerular, tubular, nephrotic, contamination)?
5. Are appropriate reflex/confirmatory tests recommended?

Quality Audit

• Specimen type and collection method documented
• Time from collection to analysis < 2 hours (or refrigerated)
• Dipstick reagent strip QC performed per manufacturer schedule
• All dipstick parameters recorded and interpreted
• Microscopy performed on centrifuged specimen per CLSI GP16-A3
• Formed elements reported per HPF (RBC, WBC) or per LPF (casts, squamous)
• Squamous epithelial cell count assessed for specimen contamination
• Casts identified and typed correctly (hyaline, granular, RBC, WBC, waxy, fatty)
• Crystals identified with clinical significance noted
• Dipstick and microscopy findings correlated for consistency
• Reflex testing recommendations provided for abnormal findings
• Automated microscopy results confirmed by manual review when flagged
• QC documentation maintained for reagent strips and automated analyzers

Guidelines

• Always assess specimen adequacy before interpreting microscopy; more than 5 squamous epithelial cells per LPF indicates contamination and warrants recollection for most clinical questions
• Correlate dipstick blood with microscopic RBC count; positive dipstick blood without RBCs suggests hemoglobinuria or myoglobinuria requiring further workup
• RBC casts are pathognomonic for glomerulonephritis — never dismiss them as artifact; if seen, recommend nephrology consultation regardless of other findings
• Cystine crystals are always pathologic and indicate cystinuria requiring metabolic evaluation; no other crystal type has this level of diagnostic certainty
• Dipstick protein primarily detects albumin; it will miss Bence Jones proteins (light chains) and tubular proteinuria — order urine protein electrophoresis or total protein when clinically indicated
• Report microscopy using a standardized format (per HPF for cells, per LPF for casts) to ensure inter-observer consistency
• For first morning void specimens, a negative protein result is more reassuring than a random void negative, as orthostatic proteinuria is excluded
• Perform reflex manual microscopy when automated urine analyzers flag abnormal results; automated systems have limited ability to classify cast subtypes and crystal types accurately